Exploring the benefits and challenges of establishing a DRI-like process for bioactives
- Autores
- Lupton, Joanne R.; Atkinson, Stephanie A.; Chang, Namsoo; Fraga, César Guillermo; Levy, Joseph; Messina, Mark; Richardson, David P.; van Ommen, Ben; Yang, Yuexin; Griffiths, James C.; Hathcock, John
- Año de publicación
- 2014
- Idioma
- inglés
- Tipo de recurso
- artículo
- Estado
- versión publicada
- Descripción
- Bioactives can be defined as: "Constituents in foods or dietary supplements, other than those needed to meet basic human nutritional needs, which are responsible for changes in health status" (Office of Disease Prevention and Health Promotion, Office of Public Health and Science, Department of Health and Human Services in Fed Reg 69:55821-55822, 2004). Although traditional nutrients, such as vitamins, minerals, protein, essential fatty acids and essential amino acids, have dietary reference intake (DRI) values, there is no such evaluative process for bioactives. For certain classes of bioactives, substantial scientific evidence exists to validate a relationship between their intake and enhanced health conditions or reduced risk of disease. In addition, the study of bioactives and their relationship to disease risk is a growing area of research supported by government, academic institutions, and food and supplement manufacturers. Importantly, consumers are purchasing foods containing bioactives, yet there is no evaluative process in place to let the public know how strong the science is behind the benefits or the quantitative amounts needed to achieve these beneficial health effects. This conference, Bioactives: Qualitative Nutrient Reference Values for Life-stage Groups?, explored why it is important to have a DRI-like process for bioactives and challenges for establishing such a process.
Fil: J. R. Lupton.
Fil: S. A. Atkinson.
Fil: N. Chang.
Fil: Fraga, César Guillermo. Consejo Nacional de Investigaciones Científicas y Técnicas. Oficina de Coordinación Administrativa Houssay. Instituto de Bioquímica y Medicina Molecular. Universidad de Buenos Aires. Facultad Medicina. Instituto de Bioquímica y Medicina Molecular; Argentina. Universidad de Buenos Aires. Facultad de Farmacia y Bioquímica. Departamento de Química Analitica y Fisicoquímica. Cátedra de Fisicoquímica; Argentina
Fil: J. Levy.
Fil: M. Messina.
Fil: D. P. Richardson.
Fil: B. van Ommen.
Fil: Y. Yang.
Fil: J. C. Griffiths.
Fil: J. Hathcock. - Materia
-
antioxidants
bioactives
flavonoids
carotenoids - Nivel de accesibilidad
- acceso abierto
- Condiciones de uso
- https://creativecommons.org/licenses/by-nc-sa/2.5/ar/
- Repositorio
- Institución
- Consejo Nacional de Investigaciones Científicas y Técnicas
- OAI Identificador
- oai:ri.conicet.gov.ar:11336/102132
Ver los metadatos del registro completo
id |
CONICETDig_b649cbf85006640de6a3c7271c2419ab |
---|---|
oai_identifier_str |
oai:ri.conicet.gov.ar:11336/102132 |
network_acronym_str |
CONICETDig |
repository_id_str |
3498 |
network_name_str |
CONICET Digital (CONICET) |
spelling |
Exploring the benefits and challenges of establishing a DRI-like process for bioactivesLupton, Joanne R.Atkinson, Stephanie A.Chang, NamsooFraga, César GuillermoLevy, JosephMessina, MarkRichardson, David P.van Ommen, BenYang, YuexinGriffiths, James C.Hathcock, Johnantioxidantsbioactivesflavonoidscarotenoidshttps://purl.org/becyt/ford/1.6https://purl.org/becyt/ford/1Bioactives can be defined as: "Constituents in foods or dietary supplements, other than those needed to meet basic human nutritional needs, which are responsible for changes in health status" (Office of Disease Prevention and Health Promotion, Office of Public Health and Science, Department of Health and Human Services in Fed Reg 69:55821-55822, 2004). Although traditional nutrients, such as vitamins, minerals, protein, essential fatty acids and essential amino acids, have dietary reference intake (DRI) values, there is no such evaluative process for bioactives. For certain classes of bioactives, substantial scientific evidence exists to validate a relationship between their intake and enhanced health conditions or reduced risk of disease. In addition, the study of bioactives and their relationship to disease risk is a growing area of research supported by government, academic institutions, and food and supplement manufacturers. Importantly, consumers are purchasing foods containing bioactives, yet there is no evaluative process in place to let the public know how strong the science is behind the benefits or the quantitative amounts needed to achieve these beneficial health effects. This conference, Bioactives: Qualitative Nutrient Reference Values for Life-stage Groups?, explored why it is important to have a DRI-like process for bioactives and challenges for establishing such a process.Fil: J. R. Lupton.Fil: S. A. Atkinson.Fil: N. Chang.Fil: Fraga, César Guillermo. Consejo Nacional de Investigaciones Científicas y Técnicas. Oficina de Coordinación Administrativa Houssay. Instituto de Bioquímica y Medicina Molecular. Universidad de Buenos Aires. Facultad Medicina. Instituto de Bioquímica y Medicina Molecular; Argentina. Universidad de Buenos Aires. Facultad de Farmacia y Bioquímica. Departamento de Química Analitica y Fisicoquímica. Cátedra de Fisicoquímica; ArgentinaFil: J. Levy.Fil: M. Messina.Fil: D. P. Richardson.Fil: B. van Ommen.Fil: Y. Yang.Fil: J. C. Griffiths.Fil: J. Hathcock.Springer2014-02info:eu-repo/semantics/articleinfo:eu-repo/semantics/publishedVersionhttp://purl.org/coar/resource_type/c_6501info:ar-repo/semantics/articuloapplication/pdfapplication/pdfhttp://hdl.handle.net/11336/102132Lupton, Joanne R.; Atkinson, Stephanie A.; Chang, Namsoo; Fraga, César Guillermo; Levy, Joseph; et al.; Exploring the benefits and challenges of establishing a DRI-like process for bioactives; Springer; European Journal of Nutrition; 53; suppl 1; 2-2014; 1-91436-62071436-6215CONICET DigitalCONICETenginfo:eu-repo/semantics/altIdentifier/url/https://link.springer.com/article/10.1007/s00394-014-0666-3info:eu-repo/semantics/altIdentifier/doi/10.1007/s00394-014-0666-3info:eu-repo/semantics/openAccesshttps://creativecommons.org/licenses/by-nc-sa/2.5/ar/reponame:CONICET Digital (CONICET)instname:Consejo Nacional de Investigaciones Científicas y Técnicas2025-09-29T09:45:38Zoai:ri.conicet.gov.ar:11336/102132instacron:CONICETInstitucionalhttp://ri.conicet.gov.ar/Organismo científico-tecnológicoNo correspondehttp://ri.conicet.gov.ar/oai/requestdasensio@conicet.gov.ar; lcarlino@conicet.gov.arArgentinaNo correspondeNo correspondeNo correspondeopendoar:34982025-09-29 09:45:39.076CONICET Digital (CONICET) - Consejo Nacional de Investigaciones Científicas y Técnicasfalse |
dc.title.none.fl_str_mv |
Exploring the benefits and challenges of establishing a DRI-like process for bioactives |
title |
Exploring the benefits and challenges of establishing a DRI-like process for bioactives |
spellingShingle |
Exploring the benefits and challenges of establishing a DRI-like process for bioactives Lupton, Joanne R. antioxidants bioactives flavonoids carotenoids |
title_short |
Exploring the benefits and challenges of establishing a DRI-like process for bioactives |
title_full |
Exploring the benefits and challenges of establishing a DRI-like process for bioactives |
title_fullStr |
Exploring the benefits and challenges of establishing a DRI-like process for bioactives |
title_full_unstemmed |
Exploring the benefits and challenges of establishing a DRI-like process for bioactives |
title_sort |
Exploring the benefits and challenges of establishing a DRI-like process for bioactives |
dc.creator.none.fl_str_mv |
Lupton, Joanne R. Atkinson, Stephanie A. Chang, Namsoo Fraga, César Guillermo Levy, Joseph Messina, Mark Richardson, David P. van Ommen, Ben Yang, Yuexin Griffiths, James C. Hathcock, John |
author |
Lupton, Joanne R. |
author_facet |
Lupton, Joanne R. Atkinson, Stephanie A. Chang, Namsoo Fraga, César Guillermo Levy, Joseph Messina, Mark Richardson, David P. van Ommen, Ben Yang, Yuexin Griffiths, James C. Hathcock, John |
author_role |
author |
author2 |
Atkinson, Stephanie A. Chang, Namsoo Fraga, César Guillermo Levy, Joseph Messina, Mark Richardson, David P. van Ommen, Ben Yang, Yuexin Griffiths, James C. Hathcock, John |
author2_role |
author author author author author author author author author author |
dc.subject.none.fl_str_mv |
antioxidants bioactives flavonoids carotenoids |
topic |
antioxidants bioactives flavonoids carotenoids |
purl_subject.fl_str_mv |
https://purl.org/becyt/ford/1.6 https://purl.org/becyt/ford/1 |
dc.description.none.fl_txt_mv |
Bioactives can be defined as: "Constituents in foods or dietary supplements, other than those needed to meet basic human nutritional needs, which are responsible for changes in health status" (Office of Disease Prevention and Health Promotion, Office of Public Health and Science, Department of Health and Human Services in Fed Reg 69:55821-55822, 2004). Although traditional nutrients, such as vitamins, minerals, protein, essential fatty acids and essential amino acids, have dietary reference intake (DRI) values, there is no such evaluative process for bioactives. For certain classes of bioactives, substantial scientific evidence exists to validate a relationship between their intake and enhanced health conditions or reduced risk of disease. In addition, the study of bioactives and their relationship to disease risk is a growing area of research supported by government, academic institutions, and food and supplement manufacturers. Importantly, consumers are purchasing foods containing bioactives, yet there is no evaluative process in place to let the public know how strong the science is behind the benefits or the quantitative amounts needed to achieve these beneficial health effects. This conference, Bioactives: Qualitative Nutrient Reference Values for Life-stage Groups?, explored why it is important to have a DRI-like process for bioactives and challenges for establishing such a process. Fil: J. R. Lupton. Fil: S. A. Atkinson. Fil: N. Chang. Fil: Fraga, César Guillermo. Consejo Nacional de Investigaciones Científicas y Técnicas. Oficina de Coordinación Administrativa Houssay. Instituto de Bioquímica y Medicina Molecular. Universidad de Buenos Aires. Facultad Medicina. Instituto de Bioquímica y Medicina Molecular; Argentina. Universidad de Buenos Aires. Facultad de Farmacia y Bioquímica. Departamento de Química Analitica y Fisicoquímica. Cátedra de Fisicoquímica; Argentina Fil: J. Levy. Fil: M. Messina. Fil: D. P. Richardson. Fil: B. van Ommen. Fil: Y. Yang. Fil: J. C. Griffiths. Fil: J. Hathcock. |
description |
Bioactives can be defined as: "Constituents in foods or dietary supplements, other than those needed to meet basic human nutritional needs, which are responsible for changes in health status" (Office of Disease Prevention and Health Promotion, Office of Public Health and Science, Department of Health and Human Services in Fed Reg 69:55821-55822, 2004). Although traditional nutrients, such as vitamins, minerals, protein, essential fatty acids and essential amino acids, have dietary reference intake (DRI) values, there is no such evaluative process for bioactives. For certain classes of bioactives, substantial scientific evidence exists to validate a relationship between their intake and enhanced health conditions or reduced risk of disease. In addition, the study of bioactives and their relationship to disease risk is a growing area of research supported by government, academic institutions, and food and supplement manufacturers. Importantly, consumers are purchasing foods containing bioactives, yet there is no evaluative process in place to let the public know how strong the science is behind the benefits or the quantitative amounts needed to achieve these beneficial health effects. This conference, Bioactives: Qualitative Nutrient Reference Values for Life-stage Groups?, explored why it is important to have a DRI-like process for bioactives and challenges for establishing such a process. |
publishDate |
2014 |
dc.date.none.fl_str_mv |
2014-02 |
dc.type.none.fl_str_mv |
info:eu-repo/semantics/article info:eu-repo/semantics/publishedVersion http://purl.org/coar/resource_type/c_6501 info:ar-repo/semantics/articulo |
format |
article |
status_str |
publishedVersion |
dc.identifier.none.fl_str_mv |
http://hdl.handle.net/11336/102132 Lupton, Joanne R.; Atkinson, Stephanie A.; Chang, Namsoo; Fraga, César Guillermo; Levy, Joseph; et al.; Exploring the benefits and challenges of establishing a DRI-like process for bioactives; Springer; European Journal of Nutrition; 53; suppl 1; 2-2014; 1-9 1436-6207 1436-6215 CONICET Digital CONICET |
url |
http://hdl.handle.net/11336/102132 |
identifier_str_mv |
Lupton, Joanne R.; Atkinson, Stephanie A.; Chang, Namsoo; Fraga, César Guillermo; Levy, Joseph; et al.; Exploring the benefits and challenges of establishing a DRI-like process for bioactives; Springer; European Journal of Nutrition; 53; suppl 1; 2-2014; 1-9 1436-6207 1436-6215 CONICET Digital CONICET |
dc.language.none.fl_str_mv |
eng |
language |
eng |
dc.relation.none.fl_str_mv |
info:eu-repo/semantics/altIdentifier/url/https://link.springer.com/article/10.1007/s00394-014-0666-3 info:eu-repo/semantics/altIdentifier/doi/10.1007/s00394-014-0666-3 |
dc.rights.none.fl_str_mv |
info:eu-repo/semantics/openAccess https://creativecommons.org/licenses/by-nc-sa/2.5/ar/ |
eu_rights_str_mv |
openAccess |
rights_invalid_str_mv |
https://creativecommons.org/licenses/by-nc-sa/2.5/ar/ |
dc.format.none.fl_str_mv |
application/pdf application/pdf |
dc.publisher.none.fl_str_mv |
Springer |
publisher.none.fl_str_mv |
Springer |
dc.source.none.fl_str_mv |
reponame:CONICET Digital (CONICET) instname:Consejo Nacional de Investigaciones Científicas y Técnicas |
reponame_str |
CONICET Digital (CONICET) |
collection |
CONICET Digital (CONICET) |
instname_str |
Consejo Nacional de Investigaciones Científicas y Técnicas |
repository.name.fl_str_mv |
CONICET Digital (CONICET) - Consejo Nacional de Investigaciones Científicas y Técnicas |
repository.mail.fl_str_mv |
dasensio@conicet.gov.ar; lcarlino@conicet.gov.ar |
_version_ |
1844613429392834560 |
score |
13.070432 |